Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 1, 2017 | $7.65B |
| FY2017, ended Dec 31, 2017 | $8.13B |
| FY2018, ended Dec 30, 2018 | $10.3B |
| FY2019, ended Dec 29, 2019 | $11.3B |
| FY2020, ended Jan 3, 2021 | $14.9B |
| FY2021, ended Jan 2, 2022 | $20.3B |
| FY2022, ended Jan 1, 2023 | $12.3B |
| FY2023, ended Dec 31, 2023 | $14.4B |
| FY2024, ended Dec 29, 2024 | $14.7B |
| FY2025, ended Dec 28, 2025 | $14.3B |
| Trailing 12 months to Sep 6, 2026 (through Q3 FY2026) | $11.2B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 1, 2017 | $2.47B |
| FY2017, ended Dec 31, 2017 | $2.79B |
| FY2018, ended Dec 30, 2018 | $3.43B |
| FY2019, ended Dec 29, 2019 | $3.62B |
| FY2020, ended Jan 3, 2021 | $4.12B |
| FY2021, ended Jan 2, 2022 | $4.36B |
| FY2022, ended Jan 1, 2023 | $4.54B |
| FY2023, ended Dec 31, 2023 | $4.48B |
| FY2024, ended Dec 29, 2024 | $4.71B |
| FY2025, ended Dec 28, 2025 | $4.94B |
| Trailing 12 months to Sep 6, 2026 (through Q3 FY2026) | $5.07B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 1, 2017 | $215M | $234M |
| FY2017, ended Dec 31, 2017 | $278M | $251M |
| FY2018, ended Dec 30, 2018 | $362M | $274M |
| FY2019, ended Dec 29, 2019 | $401M | $411M |
| FY2020, ended Jan 3, 2021 | $491M | $504M |
| FY2021, ended Jan 2, 2022 | $510M | $560M |
| FY2022, ended Jan 1, 2023 | $452M | $388M |
| FY2023, ended Dec 31, 2023 | $519M | $485M |
| FY2024, ended Dec 29, 2024 | $584M | $512M |
| FY2025, ended Dec 28, 2025 | $602M | $672M |
| Trailing 12 months to Sep 6, 2026 (through Q3 FY2026) | $609M | $636M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 1, 2017 | $42.8M |
| FY2017, ended Dec 31, 2017 | $35.8M |
| FY2018, ended Dec 30, 2018 | $25.4M |
| FY2019, ended Dec 29, 2019 | $191M |
| FY2020, ended Jan 3, 2021 | $169M |
| FY2021, ended Jan 2, 2022 | $148M |
| FY2022, ended Jan 1, 2023 | $60.4M |
| FY2023, ended Dec 31, 2023 | $114M |
| FY2024, ended Dec 29, 2024 | $186M |
| FY2025, ended Dec 28, 2025 | $126M |
| Trailing 12 months to Sep 6, 2026 (through Q3 FY2026) | $229M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 1, 2017 | $2.19B |
| FY2017, ended Dec 31, 2017 | $3.15B |
| FY2018, ended Dec 30, 2018 | $3.53B |
| FY2019, ended Dec 29, 2019 | $4.11B |
| FY2020, ended Jan 3, 2021 | $4.12B |
| FY2021, ended Jan 2, 2022 | $5.07B |
| FY2022, ended Jan 1, 2023 | $5.02B |
| FY2023, ended Dec 31, 2023 | $4.99B |
| FY2024, ended Dec 29, 2024 | $14.7M |
| FY2025, ended Dec 28, 2025 | $14.6M |
| Trailing 12 months to Sep 6, 2026 (through Q3 FY2026) | $4.89B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 31.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 1, 2017 | 48.1M |
| FY2017, ended Dec 31, 2017 | 43.0M |
| FY2018, ended Dec 30, 2018 | 41.0M |
| FY2019, ended Dec 29, 2019 | 38.7M |
| FY2020, ended Jan 3, 2021 | 38.8M |
| FY2021, ended Jan 2, 2022 | 36.0M |
| FY2022, ended Jan 1, 2023 | 35.4M |
| FY2023, ended Dec 31, 2023 | 34.8M |
| FY2024, ended Dec 29, 2024 | 34.3M |
| FY2025, ended Dec 28, 2025 | 33.6M |
| Trailing 12 months to Sep 6, 2026 (through Q3 FY2026) | 32.9M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Jan 1, 2017 | $300M | $18.6M |
| FY2017, ended Dec 31, 2017 | $1.06B | $20.7M |
| FY2018, ended Dec 30, 2018 | $591M | $22.8M |
| FY2019, ended Dec 29, 2019 | $699M | $20.3M |
| FY2020, ended Jan 3, 2021 | $305M | $24.2M |
| FY2021, ended Jan 2, 2022 | $1.32B | $28.7M |
| FY2022, ended Jan 1, 2023 | $294M | $28.7M |
| FY2023, ended Dec 31, 2023 | $269M | $37.5M |
| FY2024, ended Dec 29, 2024 | $330M | $43.3M |
| FY2025, ended Dec 28, 2025 | $358M | $44.6M |
| Trailing 12 months to Sep 6, 2026 (through Q3 FY2026) | $388M | $43.8M |
Valuation
At current price- Market Cap
- $10.3B
- P/E
- 16.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.0×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 13.7×
Growth
Trailing 12 months- Revenue (TTM)
- $5.07B
- Revenue Growth YoY
- 4.5%
- Revenue CAGR 3Y
- 2.9%
- Revenue CAGR 5Y
- 3.7%
- EPS Growth YoY
- 6.1%
- Net Income Growth YoY
- 3.4%
Profitability
Trailing 12 months- Gross Margin
- 40.0%
- Operating Margin
- 19.7%
- Net Margin
- 12.0%
- FCF Margin
- 12.5%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $609M
- EPS (diluted)
- $18.15
- EBITDA
- $1.09B
- Operating Income
- $1000M
Balance Sheet
As of Sep 6, 2026- Cash and cash equivalents
- $229M
- Total Debt
- $4.89B
- Net Debt
- $4.66B
- Total Assets
- $1.77B
- Total Liabilities
- $5.72B
- Shareholders' Equity
- −$3.96B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $760M
- Capital Expenditure
- $125M
- Free Cash Flow
- $636M
Dividends and risk
Last 12 months- Dividend Yield
- 2.5%
- Dividend / Share
- $7.71
- Beta (5Y)
- 0.95
Every ratio is calculated from the company’s reported figures.